Jeffrey Hammel - Concepedia

Author

Jeffrey Hammel

Also Known As

J HAMMEL, J Hammel, J. Hammel, J. P. Hammel, J.P. Hammel, J. P. Hammel, JEFFREY HAMMEL, JEFFREY P. HAMMEL, Janine Hammel, Jeffrey Hammel

193

Publications

9.8K

Citations

H-Index

166

Concepts

All Affiliations

Cleveland Clinic Institute for Clinical Pharmacodynamics (United States)Cleveland Foundation Cleveland Clinic Lerner College of Medicine University at Buffalo, State University of New York

About

Jeffrey Hammel is an author at Cleveland Clinic specializing in medicine, gastroenterology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	47	3.3K
2	Health Sciences	6	6	213
3	Public Health	5	5	191
4	Nursing	3	3	156
5	Natural Sciences	1	1	52

Jeffrey Hammel

110

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke Irene Katzan, Anthony J. Furlan, Lynne E. Lloyd, JAMA	2000	659
Prospective, Randomized, Controlled Trial Between a Pathway of Controlled Rehabilitation With Early Ambulation and Diet and Traditional Postoperative Care After Laparotomy and Intestinal Resection Conor P. Delaney, Massarat Zutshi, Anthony J. Senagore, Diseases of the Colon & Rectum	2003	494
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array Peter J. Mazzone, Jeffrey Hammel, Raed A. Dweik, Thorax	2007	322
Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy Isabella Mor, J. Vogel, André da Luz Moreira, Diseases of the Colon & Rectum	2008	298
Use of Exhaled Nitric Oxide Measurement to Identify a Reactive, at-Risk Phenotype among Patients with Asthma Raed A. Dweik, Ronald L. Sorkness, Sally E. Wenzel, American Journal of Respiratory and Critical Care Medicine	2010	270
NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response Raed A. Dweik, Suzy Comhair, Benjamin Gaston, Proceedings of the National Academy of Sciences	2001	262
Predictors of response to infliximab in patients with Crohn's disease Mansour A. Parsi, Jean–Paul Achkar, S G Richardson, Gastroenterology InflammationChronic Inflammatory DiseasesAnti-inflammatoryAutoimmune DiseaseImmunology	2002	256
Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients Kweku A. Appau, Victor W. Fazio, Bo Shen, Journal of Gastrointestinal Surgery Adverse Postoperative OutcomesGastroenterologyOutcomes ResearchPostoperative TreatmentSurgery	2008	247
Differential Effectiveness of Etanercept and Infliximab in the Treatment of Ocular Inflammation Anat Galor, Víctor Pérez, Jeffrey Hammel, Ophthalmology InflammationDifferential EffectivenessOcular DiseaseAnti-inflammatoryOcular Inflammation	2006	209
Risk Factors for Diseases of Ileal Pouch–Anal Anastomosis After Restorative Proctocolectomy for Ulcerative Colitis Bo Shen, Victor W. Fazio, Feza H. Remzi, Clinical Gastroenterology and Hepatology ProctologyIleal Pouch–anal AnastomosisGastroenterologyVisceral SurgerySurgery	2006	203

Page 1